News List

VISEN Pharmaceutical's TransCon C-type natriuretic peptide Phase II clinical trial application approved in China
2021-02-09

January 7, VISEN Pharmaceuticals announced that it had submitted TransCon CNP (TransCon C-type natri

Progress in the development of new and efficient diabetes treatment drugs
2021-01-20

Recently, Wang Junfeng's research team from Hefei Institute of Material Science, Chinese Academy

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA
2020-12-22

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S.

Merck's new HIV drug Pedro (Doravirin) was approved in China
2020-12-09

Merck announced recentlythat its new HIV drug Pedro (doravirin tablets) has been officially approved

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV
2020-10-18

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shion

European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis
2020-09-28

Gilead Sciences and Galapagos NV today announced that the European Commission (EC) has granted marke

Gastrointestinal stromal tumor (GIST) targeted new drugs! Avapritinib will be approved in the EU in September
2020-07-29

Blueprint Medicines announced that the European Medicines Agency (EMA) Committee for Medicinal Produ